These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10877055)

  • 1. Pentostatin (Nipent) in T-cell lymphomas.
    Kurzrock R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):64-6. PubMed ID: 10877055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
    Foss FM
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of T cell lymphomas with pentostatin.
    Kurzrock R
    Ann N Y Acad Sci; 2001 Sep; 941():200-5. PubMed ID: 11594574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions for pentostatin (Nipent) usage in dermatology.
    Heald P
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):3-8. PubMed ID: 10877044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.
    Tsimberidou AM; Giles F; Duvic M; Fayad L; Kurzrock R
    Cancer; 2004 Jan; 100(2):342-9. PubMed ID: 14716770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.
    Kurzrock R; Pilat S; Duvic M
    J Clin Oncol; 1999 Oct; 17(10):3117-21. PubMed ID: 10506607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
    Weiss MA
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):41-3. PubMed ID: 10877051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentostatin (Nipent): a review of potential toxicity and its management.
    Margolis J; Grever MR
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):9-14. PubMed ID: 10877045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
    Dang NH; Hagemeister FB; Duvic M; Romaguera JE; Younes A; Jones D; Samuels B; Fayad LE; Pro B; Samaniego F; Sarris A; Goy A; McLaughlin P; Tong AT; Walker PL; Tiongson LP; Smith TL; Huh YO; Morimoto C; Rodriguez MA
    Oncol Rep; 2003; 10(5):1513-8. PubMed ID: 12883733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentostatin treatment of cutaneous T-cell lymphoma.
    Dearden C; Matutes E; Catovsky D
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):37-40. PubMed ID: 10887643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group.
    Tobinai K; Shimoyama M; Inoue S; Takayasu S; Mikuni C; Kozuru M; Oda S; Nakajima H
    Jpn J Clin Oncol; 1992 Jun; 22(3):164-71. PubMed ID: 1518164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible pentostatin-induced symptomatic hyponatremia.
    Bruno JJ; Canada TW
    Pharmacotherapy; 2007 Jan; 27(1):164-9. PubMed ID: 17192171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pentostatin treatment for a patient with chronic type adult T-cell leukemia undergoing hemodialysis].
    Arima N; Sugiyama T
    Rinsho Ketsueki; 2005 Nov; 46(11):1191-5. PubMed ID: 16440802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Ann Oncol; 1999 Dec; 10(12):1493-8. PubMed ID: 10643542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma.
    Greiner D; Olsen EA; Petroni G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):950-5. PubMed ID: 9204061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.